Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition

Molecular Pharmacology

Volumn 78, Issue 2, 2010, Pages 260-268

  Rossi, Silvia ^a,b   De Chiara, Valentina ^a,b   Musella, Alessandra ^a,b   Sacchetti, Lucia ^c   Cantarella, Cristina ^a,b   Castelli, Maura ^a,b   Cavasinni, Francesca ^a,b   Motta, Caterina ^a,b   Studer, Valeria ^a,b   Bernardi, Giorgio ^a,b   Cravatt, Benjamin F ^d   Maccarrone, Mauro ^b,e   Usiello, Alessandro ^f,g   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TERAMO   (Italy)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; ENZYME INHIBITION; GABAERGIC TRANSMISSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; MOUSE MUTANT; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SOCIAL STRESS; TRANQUILIZING ACTIVITY;

AMIDOHYDROLASES; ANIMALS; ANTI-ANXIETY AGENTS; CORPUS STRIATUM; ENZYME INHIBITORS; MICE; RECEPTOR, CANNABINOID, CB1;

EID: 77954902977     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.064196     Document Type: Article

References (57)

1. Ade KK and Lovinger DM (2007) Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. J Neurosci 27:2403-2409.
2. Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, et al. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci 25:8432-8438. (Pubitemid 41324729)
3. Avgustinovich DF, Kovalenko IL, and Kudryavtseva NN (2005) A model of anxious depression: persistence of behavioral pathology. Neurosci Behav Physiol 35:917-924.
4. Beishuizen A and Thijs LG (2003) Endotoxin and the hypothalamo-pituitary- adrenal (HPA) axis. J Endotoxin Res 9:3-24.
5. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868.
6. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, and Herman JP (2008) Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 19:175-180.
7. Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, and Piomelli D (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62:1103-1110.
8. Centonze D, Rossi S, Mercaldo V, Napoli I, Ciotti MT, De Chiara V, Musella A, Prosperetti C, Calabresi P, Bernardi G, et al. (2008) Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol Psychiatry 63:963-973.
9. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, and Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology 198:449-460.
10. Coddington E, Lewis C, Rose JD, and Moore FL (2007) Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 148:493-500.
11. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, and Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371-9376.
12. Cutolo M, Sulli A, Pizzorni C, Secchi ME, Soldano S, Seriolo B, Straub RH, Otsa K, and Maestroni GJ (2006) Circadian rhythms: glucocorticoids and arthritis. Ann NY Acad Sci 1069:289-299.
13. De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, et al. (2010) Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 35:374-387.
14. Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, et al. (2008) The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci 37:335-345.
15. Favilla C, Abel T, and Kelly MP (2008) Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J Neurosci 28:13952-13956.
16. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, and Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313:352-358.
17. Ganon-Elazar E and Akirav I (2009) Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29:11078-11088.
18. Gerdeman G and Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-471. (Pubitemid 32062158)
19. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, et al. (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102:18620-18625.
20. Hack SP, Vaughan CW, and Christie MJ (2003) Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology 45:575-584.
21. Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, and Goldberg S (2009) Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl) 204:607-616.
22. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, Ferrell RE, Goldman D, and Manuck SB (2009) Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry 66:9-16.
23. Harvey VL and Stephens GJ (2004) Mechanism of GABA receptor-mediated inhibition of spontaneous GABA release onto cerebellar Purkinje cells. Eur J Neurosci 20:684-700.
24. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, and Cullinan WE (2003) Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24:151-180.
25. Hill MN and Gorzalka BB (2006) Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure. Psychoneuroendocrinology 31:526-536.
26. Hill MN, Karacabeyli ES, and Gorzalka BB (2007) Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32:350-357.
27. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, and Gorzalka BB (2009) Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34:2733-2745.
28. Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, and Gorzalka BB (2005) Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 30:508-515.
29. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, et al. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108-1112.
30. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, and Porrino LJ (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (Suppl 1):345-358.
31. Huang CC, Lo SW, and Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532:731-748.
32. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81.
33. Kim KS, Lee KW, Baek IS, Lim CM, Krishnan V, Lee JK, Nestler EJ, and Han PL (2008) Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxietyrelated behavior. J Neurochem 107:105-115.
34. Lichtman AH and Martin BR (2005) Cannabinoid tolerance and dependence. Handb Exp Pharmacol 168:691-717.
35. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180-185.
36. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agrò A, et al. (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11:152-159.
37. Macfarlane DP, Forbes S, and Walker BR (2008) Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J Endocrinol 197:189-204.
38. Mathew SJ and Ho S (2006) Etiology and neurobiology of social anxiety disorder. J Clin Psychiatry 67 (Suppl 12):9-13.
39. McKinney MK and Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432.
40. Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, and Di Marzo V (2009) Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34:593-606.
41. Moreira FA, Kaiser N, Monory K, and Lutz B (2008) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoiddegrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54:141-150. (Pubitemid 350299416)
42. Murphy GJ and Isaacson JS (2003) Presynaptic cyclic nucleotide-gated ion channels modulate neurotransmission in the mammalian olfactory bulb. Neuron 37:639-647.
43. Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M, and Centonze D (2009) TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci 40:89-97.
44. Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, and Lichtman AH (2007) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 192:61-70.
45. Patel S and Hillard CJ (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318:304-311.
46. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, and Hillard CJ (2004) Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145:5431-5438.
47. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
48. Rademacher DJ and Hillard CJ (2007) Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry 31:633-641.
49. Reiman EM, Raichle ME, Robins E, Mintun MA, Fusselman MJ, Fox PT, Price JL, and Hackman KA (1989) Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 46:493-500.
50. Rogan MT, Leon KS, Perez DL, and Kandel ER (2005) Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse. Neuron 46:309-320.
51. Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, and Centonze D (2008) Chronic psychoemotional stress impairs cannabinoidreceptor- mediated control of GABA transmission in the striatum. J Neurosci 28:7284-7292.
52. Rubino T, Realini N, Castiglioni C, Guidali C, Viganó D, Marras E, Petrosino S, Perletti G, Maccarrone M, Di Marzo V, et al. (2008) Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 18:1292-1301.
53. Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, et al. (2008) The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology 54:129-140.
54. Seckl JR and Meaney MJ (2004) Glucocorticoid programming. Ann NY Acad Sci 1032:63-84.
55. Szabo B, Dörner L, Pfreundtner C, Nörenberg W, and Starke K (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85:395-403.
56. Yoo HK, Kim MJ, Kim SJ, Sung YH, Sim ME, Lee YS, Song SY, Kee BS, and Lyoo IK (2005) Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur J Neurosci 22:2089-2094.
57. Zhang HT, Huang Y, Masood A, Stolinski LR, Li Y, Zhang L, Dlaboga D, Jin SL, Conti M, and O'Donnell JM (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 33:1611-1623.